Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 2/2018

Ausgabe 2/2018

Inhaltsverzeichnis ( 21 Artikel )

08.06.2018 | Review Article | Ausgabe 2/2018

Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications

Chengliang Huang, Sitong Liu, Xiang Tong, Hong Fan

18.05.2018 | Original Article | Ausgabe 2/2018

The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells

Hoi-Wing Leung, Chun-Hay Ko, Grace Gar-Lee Yue, Ingrid Herr, Clara Bik-San Lau

18.05.2018 | Original Article | Ausgabe 2/2018

Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro

Jia-Feng Huang, Chun-Jie Wen, Guo-Zhi Zhao, Yi Dai, Ying Li, Lan-Xiang Wu, Hong-Hao Zhou

25.05.2018 | Original Article | Ausgabe 2/2018

Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel

Matthew Scarpelli, Murtuza Rampurwala, Jens Eickhoff, Lakeesha Carmichael, Jennifer Heideman, Kimberly Binger, Jill Kolesar, Scott Perlman, Kim Harrow, Gary Dukart, Chris Liang, Robert Jeraj, Glenn Liu, Justine Yang Bruce

28.05.2018 | Original Article | Ausgabe 2/2018

Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas

Bo Wang, Hao Yao, Xianbiao Xie, Junqiang Yin, Changye Zou, Gang Huang, Jingnan Shen

29.05.2018 | Original Article | Ausgabe 2/2018

Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia

Chunlu Gao, Shuang Hu, Meihua Guo, Xin Hai, Jin Zhou

29.05.2018 | Original Article | Ausgabe 2/2018

The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer

Al-Motassem Yousef, Mohammed Zawiah, Shorouq Al-Yacoub, Taha Kadi, Dua’ a Tantawi, Hanguin Al-Ramadhani

30.05.2018 | Original Article | Ausgabe 2/2018

Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer

Junko Tahara, Kyoko Shimizu, Nao Otsuka, Junichi Akao, Yukiko Takayama, Katsutoshi Tokushige

31.05.2018 | Original Article | Ausgabe 2/2018

Targeting ALK in pediatric RMS does not induce antitumor activity in vivo

Monika Wierdl, Lyudmila Tsurkan, Liying Chi, M. Jason Hatfield, Viktor Tollemar, Cori Bradley, Xiang Chen, Chunxu Qu, Philip M. Potter

04.06.2018 | Original Article | Ausgabe 2/2018

Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice

Ken Shimada, Kentaro Ushijima, Chisato Suzuki, Michiko Horiguchi, Hitoshi Ando, Tomomi Akita, Mizuki Shimamura, Junki Fujii, Chikamasa Yamashita, Akio Fujimura

05.06.2018 | Original Article | Ausgabe 2/2018 Open Access

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

Sakura Iizumi, Akihiko Shimomura, Tatsunori Shimoi, Kazuki Sudo, Emi Noguchi, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura

07.06.2018 | Original Article | Ausgabe 2/2018

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

Jordi Rodon, Alejandro Pérez-Fidalgo, Ian E. Krop, Howard Burris, Angel Guerrero-Zotano, Carolyn D. Britten, Carlos Becerra, Jan Schellens, Donald A. Richards, Martin Schuler, Maysa Abu-Khalaf, Faye M. Johnson, Malcolm Ranson, Jeff Edenfield, Antonio P. Silva, Wolfgang Hackl, Cornelia Quadt, David Demanse, Vincent Duval, Jose Baselga

07.06.2018 | Original Article | Ausgabe 2/2018

The pH-altering agent omeprazole affects rate but not the extent of ibrutinib exposure

Jan de Jong, Nahor Haddish-Berhane, Peter Hellemans, James Jiao, Juthamas Sukbuntherng, Daniele Ouellet

09.06.2018 | Original Article | Ausgabe 2/2018

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors

Amikar Sehdev, Theodore Karrison, Yuanyuan Zha, Linda Janisch, Michelle Turcich, Ezra E. W. Cohen, Michael Maitland, Blase N. Polite, Thomas F. Gajewski, Ravi Salgia, Navin Pinto, Marc B. Bissonnette, Gini F. Fleming, Mark J. Ratain, Manish R. Sharma

15.06.2018 | Original Article | Ausgabe 2/2018

Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients

Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, Olivier Colomban, Jérôme Guitton, Vérane Schwiertz, Véronique Regnier, Benoit You, Florence Ranchon, Raymonde Maraval-Gaget, Pascal Girard, Franck Chauvin, Gilles Freyer, Michel Tod, Emilie Henin, Véronique Trillet-Lenoir

15.06.2018 | Original Article | Ausgabe 2/2018

Pharmacokinetic and pharmacodynamic bioequivalence study of a pegfilgrastim biosimilar INTP5 in healthy subjects

Inderjeet Singh, Akash Patel, Ronak Patel, Vinu Jose

15.06.2018 | Original Article | Ausgabe 2/2018

Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors

Colin D. Weekes, Lee S. Rosen, Anna Capasso, Kit Man Wong, Weilan Ye, Maria Anderson, Bruce McCall, Jill Fredrickson, Eric Wakshull, Steve Eppler, Quyen Shon-Nguyen, Rupal Desai, Mahrukh Huseni, Priti S. Hegde, Tony Pourmohamad, Ina Rhee, Alberto Bessudo

25.06.2018 | Clinical Trial Report | Ausgabe 2/2018 Open Access

Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma

John P. Fruehauf, Monica El-Masry, Katherine Osann, Basmina Parmakhtiar, Maki Yamamoto, James G. Jakowatz

19.06.2018 | Short Communication | Ausgabe 2/2018

Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report

Fabienne Thomas, Gareth J. Veal, Souleiman El Balkhi, Thierry Lafont, Nicolas Picard, Laurence Brugières, Etienne Chatelut, Christophe Piguet

15.03.2018 | Letter to the Editor | Ausgabe 2/2018

Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

Jie Weng, Mengyun Tu, Bo Yang, Zhiyi Wang

25.06.2018 | Letter to the Editor | Ausgabe 2/2018

Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

Kyoichi Kaira

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise